SCHEMBL3726408

SCHEMBL3726408

CC(C)(C)NC1CC(COC(=O)c2ccccc2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CARM1 Q86X55 1/20 0.49
▸ PRMT6 Q96LA8 1/20 0.49
▸ ADRB2 P07550 1/20 0.47
▸ ADRB1 P08588 1/20 0.47
▸ ADRB3 P13945 1/20 0.47
▸ CHRNB2 P17787 1/20 0.45
▸ CHRNA5 P30532 1/20 0.45
▸ CHRNA7 P36544 1/20 0.45
▸ CHRNA4 P43681 1/20 0.45
▸ NPC1 O15118 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ TDP1 Q9NUW8 3/20 0.44
▸ SLC6A3 Q01959 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ HTR1A P08908 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ SCN1A P35498 1/20 0.44
▸ SCN5A Q14524 1/20 0.44
▸ SCN2A Q99250 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3726409 1.00 CARM1 (0.49) CARM1PRMT6ADRB2ADRB1ADRB3
SCHEMBL3731346 0.82 CARM1 (0.50) CARM1PRMT6CHRNB2CHRNA5CHRNA7
SCHEMBL3731344 0.82 CARM1 (0.50) CARM1PRMT6CHRNB2CHRNA5CHRNA7
SCHEMBL30418290 0.82 KMT2A (0.52) CARM1PRMT6ADRB2ADRB1ADRB3
SCHEMBL28099140 0.79 CARM1 (0.52) CARM1PRMT6CHRNB2CHRNA5CHRNA7
SCHEMBL9118362 0.77 ALDH1A1 (0.51) CARM1PRMT6CHRNB2CHRNA5CHRNA7
SCHEMBL3731771 0.77 TDP1 (0.50) CARM1PRMT6CHRNB2CHRNA5CHRNA7
SCHEMBL2022684 0.77 ALDH1A1 (0.51) CARM1PRMT6CHRNB2CHRNA5CHRNA7
SCHEMBL2023266 0.77 ALDH1A1 (0.51) CARM1PRMT6CHRNB2CHRNA5CHRNA7
SCHEMBL8525336 0.77 ALDH1A1 (0.51) CARM1PRMT6CHRNB2CHRNA5CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825155-B2 Oxindole derivative as feeding control agent DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2010-11-02 — — US disclosed
US-20090131398-A1 OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2009-05-21 — — US disclosed
EP-1935883-A1 OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT Dainippon Sumitomo Pharma Co., Ltd. (JP) 2008-06-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131398-A1 OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT GPR119, OXTR, CCKAR CARM1 410/4885PRMT6 53/4885ADRB2 723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback